Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | CRG-022 |
Trade Name | |
Synonyms | CRG 022|CRG022 |
Drug Descriptions |
CRG-022 are autologous T-lymphocytes engineered to express a chimeric antigen receptor (CAR) targeting CD22, which potentially induce tumor cell lysis (NCI Drug Dictionary). |
DrugClasses | CD22 Immune Cell Therapy 15 |
CAS Registry Number | NA |
NCIT ID | C200763 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
CRG-022 | CRG-022 | 0 | 1 |